New inhibitors of poly(ADP-ribose) polymerase (PARP)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.11, 2004-11, pp. : 1531-1551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-Ribose) Polymerase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 321-340

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

By Cosi Cristina

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 1047-1071

Informa Healthcare

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerase Inhibitors: New Pharmacological Functions and Potential Clinical Implications

Current Pharmaceutical Design, Vol. 13, Iss. 9, 2007-03 ,pp. : 933-962

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death

By Larner Andrew J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 481-487

Informa Healthcare

Access to resources Recommend Favorite

The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment

Current Drug Targets, Vol. 12, Iss. 14, 2011-01 ,pp. : 2034-2044

Bentham Science Publishers

Access to resources Recommend Favorite